STOCKSCREENR

0QLN.L

LSE

Tecan Group AG

$117.70+2.19(+1.90%)Mkt Cap: $1.48B

Key Stats

Market Cap

$1.48B

P/E Ratio

11.91

EPS

$9.88

Dividend Yield

2.23%

52-Week Range

$114.50 — $412.60

Volume

5.70K

Avg Volume

7.88K

Beta

1.11

Price Alerts for 0QLN.L

Get alerted when 0QLN.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

11.91

Forward P/E

18.86

PEG Ratio

-0.15

P/S (TTM)

1.93

P/B (TTM)

1.48

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.09%

ROA (TTM)

-0.07%

ROIC

—

Gross Margin

0.35%

Operating Margin

0.05%

Net Margin

—

Debt/Equity

0.19

Current Ratio

2.46

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.15%

EPS Growth (5Y)

+0.02%

Sales Growth (3Y)

+0.01%

Sales Growth (5Y)

+0.09%

EPS Est (This Year)

$6.24

EPS Est (Next Year)

$7.60

Dividends

Dividend Yield

—

Annual Dividend

$3.00

Payout Ratio

—

Frequency

—

Ex-Dividend Date

2025-04-14

Cash/Share

$24.58

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

12.70M

Float

12.67M

Free Float %

99.74%

Technicals

RSI (14)

44.85

SMA 20

$131.47

SMA 50

$136.73

SMA 200

$148.37

ATR (14)

4.03

Volatility (Week)

0.02%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

+1.12%

1 Week

-1.18%

1 Month

-4.92%

3 Months

-6.12%

6 Months

-19.32%

1 Year

—

YTD

-1.32%

All-Time High

$226.80

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

CH

Exchange

LSE

IPO Date

2014-07-31

Employees

3074

CEO

Monica Manotas

Index Membership

—

Website

https://www.tecan.com

Tecan Group AG (0QLN.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $1.48B, a P/E ratio of 11.91, and a dividend yield of 2.23%, 0QLN.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0QLN.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0RU5.L

Oncoinvent ASA

$49.50

+3.13%

$1.94B

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0RA9.L

Abivax S.A.

$92.20

-0.59%

$7.30B

0QND.L

Bachem Holding AG

$70.06

+2.29%

$5.24B

0L35.L

Sarepta Therapeutics, Inc.

$21.09

+2.59%

$2.11B

0IMT.L

Photocure ASA

$65.10

-4.41%

$1.73B

Frequently Asked Questions

What is Tecan Group AG's P/E ratio?

Tecan Group AG (0QLN.L) has a trailing twelve-month (TTM) P/E ratio of 11.91. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Tecan Group AG pay a dividend?

No, Tecan Group AG (0QLN.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Tecan Group AG's market cap?

Tecan Group AG (0QLN.L) has a market capitalization of $1.48 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0QLN.L performed this year?

Tecan Group AG (0QLN.L) has returned -1.32% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.